ACG Presidential Plenary to Highlight Analysis of Xifaxan Risk Reduction of Overt Hepatic Encephalopathy Recurrence Life Science Investing News
InhaleRx Pens AU$38.5 Million Funding Agreement with Clendon Biotech Capital Pharmaceutical Investing
Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis Geography
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer Pharmaceutical Investing
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares Geography
